Head of Healthcare, EMEA, Amazon Web Services
During this unprecedented COVID-19 global pandemic, cloud computing has played an important role in healthcare’s response to the disease.
The impact of COVID-19 on healthcare professionals began with a surge of new patients in need of urgent care. But new and unforeseen challenges arose as the crisis unfolded. For example, social distancing restrictions had to be navigated to keep everybody as safe as possible. The crisis led to the rapid proliferation of new research on vaccines and therapeutics, which needed to be analysed and understood for life-saving value. We have also seen a surge in misinformation, leading to new demands for accurate information from healthcare professionals.
These factors have squeezed the sector’s time, resources and personnel on all sides, which has accelerated the demand for innovative digital solutions. Around the world, healthcare organisations including the WHO, Imperial College London, Genomics England, Moderna, and UC San Diego Health are using Amazon Web Ser- vices (AWS) Cloud technology to help. Cloud computing supports these organisations by providing technology needed to measure COVID-19’s spread, to test citizens, monitor its impact, decode immune system responses, develop therapeutics, distribute and manage vaccine rollouts, and many other critical functions.
Supporting researchers
Healthcare professionals have faced a tidal wave of information about the virus. In fact, more than 300,000 medical research articles were published on the topic of COVID-19 treatment between December 2019 and May 2020.
To tackle this ‘infodemic’, a team at Imperial College London has created a global knowledge platform called REDASA (REaltime Data Analysis and Synthesis) https://www.pansurg.org/redasa. The platform combines artificial intelligence with
human expertise to help the healthcare community quickly make sense of this tidal
wave of information, ultimately finding better treatments for COVID-19 and saving
clinicians tens of thousands of hours.
Vaccine rollout
Many of us will be focused on when we can receive our COVID-19 vaccinations, and the cloud has proven to be an invaluable tool in supporting the development and rollout of these vaccines. Developing, managing, and distributing a vaccine that can fight a global pandemic requires innovation and modernized IT systems to ensure doses get to patients quickly and efficiently.
In vaccine development, Moderna’s scientists are using AWS to compress the time needed to advance drug candidates to clinical studies; increase the agility of its research, development, and manufacturing processes; and achieve results – such as personalized cancer vaccines – that would have been impossible even a few years ago.
Patient care
In patient care, there has been a boom in outpatient video consultations as digital platforms make it easier, safer and quicker and more convenient for patients to speak with practitioners.
In the UK for example, video consultation provider Attend Anywhere enabled tens of thousands of individuals to virtually see their clinicians in just a few months at the start of the crisis last year, and many more on an ongoing basis since then as trusts adopt video as a standard option provided to patients. And in the United Arab Emirates, Germany and the UK, Huma’s Remote Patient Monitoring (RPM) solution is helping to manage patients diagnosed with COVID-19 by tracking symptoms, monitoring vital signs and any deterioration, and can also automatically flag high-risk patients.
This shift to digital platforms is expected to outlast the crisis and provide long-term benefits to patients and practitioners alike.
AWS Diagnostic Development Initiative
With participation from 35 global research institutions, start-ups and businesses, last year AWS launched the ‘AWS Diagnostic Development Initiative’ (DDI) – https:// aws.amazon.com/government-education/nonprofits/disaster-response/diagnostic-dev-initiative an initial commitment of $20 million in computing credits and customised expertise to support customers working on rapid testing and accurate detection of COVID-19. Applications are open until the end of the year.
In the first phase of the initiative, AWS helped 87 organizations in 17 countries on a range of diagnostic projects, including molecular tests for antibodies, antigens, and nucleic acids; diagnostic imaging; wearables; and data analytics tools that use artificial intelligence and machine learning to detect the virus.
In the next phase, the DDI is broadening its scope to new areas including early disease detection to identify community outbreaks; prognosis to better understand disease trajectory; and public health genomics to bolster viral genome sequencing worldwide.
Beyond the crisis
Clearly, this is a pivotal moment where the healthcare industry is seeking opportunities to identify partnerships, work collaboratively, and accelerate digital innovation to address the challenges of the pandemic and the industry more broadly, using their findings to identify new ways to provide better care at scale and save more lives.
A global knowledge platform like RE- DASA at Imperial College London, for example, is immensely useful to understand and treat COVID-19 right now. But, importantly, this technology and many others like it can be applied to other forms of disease, such as cancer treatment, with a wide-ranging legacy for healthcare as a whole.
Dr James Kinross on the REDASA team explained why this kind of technology
can be transformative: “We’re never going back to a pre-digital healthcare. Life has fundamentally changed in terms of how we communicate with patients, how we empower them with information to make better decisions, and how we use digital transformation to achieve that.”
“We are still counting the human cost of this crisis,” Dr Kinross added, “but as clinicians we can see how the first truly global catastrophe in our modern world is accelerating advances in medicine and technology that could benefit people for many generations to come.”
The future of cloud computing in health- care is incredibly exciting – and the speed of innovation and adoption across healthcare will only accelerate as organisations and businesses demonstrate efficacy in real-world examples. Most importantly, these innovations can be seen and felt in patient care, and patient outcomes, around the world.
